Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 451 to 500 of 7460 in total 
Value Type: Measured
Interaction Map: High confidence

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
113\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
sh3 domain-binding glutamic acid-rich-like protein 2 (fovea-associated sh3 domain binding protein). [source:swissprot;acc:q9ujc5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
160\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
112.25\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.42539\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor cp2; transcription factor cp2, alpha globin. [source:refseq;acc:nm\_005653]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
3117.17\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2833.94\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
283.23\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
114\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
279.29\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinases regulatory subunit 1 (cks-1) (sid1334) (pnas-16 / pnas-143). [source:swissprot;acc:p33551]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13768.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11466\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2302.2\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
daz associated protein 1 isoform b; deleted in azoospermia associated protein 1. [source:refseq;acc:nm\_018959]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
671.769\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
472.945\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.4204\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin interacting protein c. [source:refseq;acc:nm\_012272]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4300.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5807.72\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.35048\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
115\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
279.29\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pnas-18. [source:sptrembl;acc:q9bzu3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
13680.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11409.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2270.9\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein-like 1; zinc-finger protein in men1 region. [source:refseq;acc:nm\_006782]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
385\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
543\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.41039\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
116\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-parvin (calponin-like integrin-linked kinase binding protein) (ch-ilkbp). [source:swissprot;acc:q9nvd7]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
668\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
475\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.40632\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cylindromatosis (turban tumor syndrome); cylindromatosis 1, turban tumor syndrome. [source:refseq;acc:nm\_015247]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1382.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1107\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
275.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator-like 1 (ralgds-like 1). [source:swissprot;acc:q9nzl6]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
13261.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11017.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2244.1\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
117\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccr4-not transcription complex, subunit 7 (ccr4-associated factor 1) (caf1) (btg1 binding factor 1). [source:swissprot;acc:q9uiv1]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1161.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
891.114\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
270.766\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
metalloprotease 1; metalloprotease 1 (pitrilysin family). [source:refseq;acc:nm\_014889]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
9276.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7090.37\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2186.1\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin activating enzyme e1-like protein. [source:refseq;acc:nm\_006395]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
122\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.39754\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
118\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-1,4 mannosyltransferase. [source:refseq;acc:nm\_019109]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9275.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7089.65\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2185.45\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
glutathione s-transferase theta 2 (ec 2.5.1.18) (gst class-theta). [source:swissprot;acc:p30712]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
324.442\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
593.094\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
268.652\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
methyltransferase like 2. [source:refseq;acc:nm\_018396]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
31\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
43\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.3871\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
119\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coa dehydrogenase, very-long-chain specific, mitochondrial precursor (ec 1.3.99.-) (vlcad). [source:swissprot;acc:p49748]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
12998.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
15138.2\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2139.7\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
estrogen-related receptor gamma (estrogen receptor related protein 3) (err gamma-2). [source:swissprot;acc:o75454]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
633.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
460.2\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.37734\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin protein ligase. [source:refseq;acc:nm\_130466]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
620\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
352.75\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
267.25\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
120\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20b; sox-like transcriptional factor; swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily e, member 1-related. [source:refseq;acc:nm\_006339]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
5136.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6895.98\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.34247\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene protein c-fos (cellular oncogene fos) (g0/g1 switch regulatory protein 7). [source:swissprot;acc:p01100]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
4932.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7033.29\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2101.02\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
signal-induced proliferation-associated 1-like 1. [source:refseq;acc:nm\_015556]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
494.417\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
359.631\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.37479\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 2 protein (ws beta-transducin repeats protein) (ws-betatrp) (williams-beuren syndrome chromosome region 13 protein). [source:swissprot;acc:q9y4p3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
817.81\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
551.434\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
266.376\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
121\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
4-aminobutyrate aminotransferase, mitochondrial precursor (ec 2.6.1.19) (gamma-amino-n-butyrate transaminase) (gaba transaminase) (gaba aminotransferase) (gaba-at) (gaba-t). [source:swissprot;acc:p80404]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
19.6667\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14.3333\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.3721\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
jun dimerization protein. [source:refseq;acc:nm\_130469]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4932.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7033.29\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2101.02\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
presenilin-like protein 1 (ec 3.4.99.-) (sppl2b protein). [source:swissprot;acc:q8tct7]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
874\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1139\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
265\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor jun-b. [source:swissprot;acc:p17275]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5579.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7488.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.3422\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
122\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
casein kinase i alpha s-like. [source:refseq;acc:nm\_145203]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2198.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1933.94\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
264.53\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
4941.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7037.11\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2095.16\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20a. [source:refseq;acc:nm\_018200]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
5140.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6893.53\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.34112\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh2-b homolog; likely ortholog of mouse sh2 domain-containing putative adapter sh2-b; sh2-b gamma signaling protein; sh2-b alpha signaling protein. [source:refseq;acc:nm\_015503]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
107\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
78\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.37179\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
123\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
24260.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18172.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.33503\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein fosb (g0/g1 switch regulatory protein 3). [source:swissprot;acc:p53539]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
4942.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7037.32\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2094.83\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative nucleoside diphosphate kinase (ec 2.7.4.6) (ndk) (ndp kinase). [source:swissprot;acc:o60361]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1905.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1643\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
262.84\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ret finger protein 2 (leukemia associated protein 5) (b-cell chronic lymphocytic leukemia tumor suppressor leu5) (putative tumor suppressor rfp2) (tripartite motif protein 13). [source:swissprot;acc:o60858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
2285.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1681.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.35944\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
124\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
brain protein 16. [source:refseq;acc:nm\_016458]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
2155.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2418.14\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
262.39\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 1 (fra-1). [source:swissprot;acc:p15407]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
4944.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7038.04\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2093.74\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3b (map1a/map1b lc3 b) (map1a/1b light chain 3 b). [source:swissprot;acc:q9gzq8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.33501\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
regulator of chromosome condensation (cell cycle regulatory protein). [source:swissprot;acc:p18754]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
3248.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2399.76\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.35386\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
125\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamate dehydrogenase 2, mitochondrial precursor (ec 1.4.1.3) (gdh). [source:swissprot;acc:p49448]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
3691.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3952.59\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
261.44\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
12471.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14561.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2090\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3a (map1a/map1b lc3 a) (map1a/1b light chain 3 a). [source:swissprot;acc:q9h492]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.33501\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable calcium-transporting atpase kiaa0703 (ec 3.6.3.8). [source:swissprot;acc:o75185]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1095.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
812.166\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.34876\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/